Dr. Fazlullah Khan

Associate Professor

fazlullah.khan@cust.edu.pk

PROFILE SUMMARY

Dr. Fazlullah Khan received his doctorate in Pharmacology and Toxicology from Tehran University of Medical Sciences, Iran in 2019 and joined academia as faculty member. He has broad research interests in the areas of Pharmacology and Toxicology. His specific field of research focuses on environmental toxicants-induced disorders. He has published scores of research publications in renowned international journals. In addition, he serves as a review editor for various international journals including Frontiers in Endocrinology and Frontiers in Pharmacology. He is member of Society of Toxicology (SOT) and the American Association of Pharmaceutical Scientists (AAPS).

QUALIFICATION
PhD	Pharmacology and Toxicology	Tehran University of Medical Sciences, Iran	2019
MPhil	Biochemistry	Hazara University Mansehra, Pakistan.	2014
Pharm-D	Pharmaceutical Sciences	University of Malakand, Dir (Lower), Pakistan	2010

TEACHING EXPERIENCE
Associate Professor	Capital University of Science and Technology (CUST), Islamabad	Since – 2024
Assistant Professor	Capital University of Science and Technology (CUST), Islamabad	2022-2023
Assistant Professor	Bashir Institute of Health Sciences,Islamabad	2020-2022

MANAGEMENT EXPERIENCE
HoD	Department of Pharmacy, Bashir Institute of Health Sciences, Islamabad	2021 – 2022

MEMBERSHIP OF PROFESSIONAL BODIES
AAPS	Member, American Association of Pharmaceutical Scientists
SOT	Member, Society of Toxicology, US

RESEARCH AREAS / INTERESTS
1.	Molecular Pharmacology
2.	Mechanistic Toxicology
3.	Endocrine Disruptors
4.	Diabetes

SR.	JOURNAL PUBLICATIONS	YEAR
1	Y. Hussain, Abdullah, F. Khan, W. Alam, H. Sardar, M. A. Khan, X. Shen, and H. Khan, “Role of quercetin in DNA repair: Possible target to combat drug resistance in diabetes,” Current Drug Targets, vol. 25, no. 10, pp. 670–682, 2024.	2024
2	F. Khan and H. Qiu, “Amyloid-β: A potential mediator of aging-related vascular pathologies,” Vascular Pharmacology, vol. 152, p. 107213, 2023.	2023
3	K. Niaz, M. A. Nawaz, S. Pervez, U. Younas, I. Shah, and F. Khan, “Total scale analysis of organic acids and their role to mitigate Alzheimer’s disease,” South African Journal of Botany, vol. 144, pp. 437–447, 2022.	2022
4	Y. Hussain, H. Khan, G. Alotaibi, F. Khan, W. Alam, M. Aschner, P. Jeandet, and L. Saso, “How curcumin targets inflammatory mediators in diabetes: Therapeutic insights and possible solutions,” Molecules, vol. 27, no. 13, p. 4058, 2022.	2022
5	Y. Hussain, Abdullah, K. F. Alsharif, M. Aschner, A. Theyab, F. Khan, L. Saso, and H. Khan, “Therapeutic role of carotenoids in blood cancer: Mechanistic insights and therapeutic potential,” Nutrients, vol. 14, no. 9, p. 1949, 2022.	2022
6	H. Khan, T. Belwal, T. Efferth, A. A. Farooqi, A. Sanches-Silva, R. A. Vacca, S. F. Nabavi, F. Khan, H. Prasad Devkota, D. Barreca et al., “Targeting epigenetics in cancer: Therapeutic potential of flavonoids,” Critical reviews in food science and nutrition, vol. 61, no. 10, pp. 1616–1639, 2021.	2021
7	T. B. Tafesse, M. H. Bule, F. Khan, M. Abdollahi, and M. Amini, “Developing novel anticancer drugs for targeted populations: An update,” Current Pharmaceutical Design, vol. 27, no. 2, pp. 250–262, 2021.	2021
8	F. Khan, M. Hodjat, M. Rahimifard, M. N. Nigjeh, M. Azizi, M. Baeeri, Z. Bayrami, M. Gholami, S. Hassani, and M. Abdollahi, “Assessment of arsenic-induced modifications in the DNA methylation of insulin-related genes in rat pancreatic islets,” Ecotoxicology and environmental safety, vol. 201, p. 110802, 2020.	2020
9	M. Baeeri, M. Rahimifard, S. M. Daghighi, F. Khan, S. A. Salami, S. Moini-Nodeh, H. Haghi-Aminjan, Z. Bayrami, F. Rezaee, and M. Abdollahi, “Cannabinoids as anti-ROS in aged pancreatic islet cells,” Life sciences, vol. 256, p. 117969, 2020.	2020
10	T. Behl, S. Bungau, K. Kumar, G. Zengin, F. Khan, A. Kumar, R. Kaur, T. Venkatachalam, D. M. Tit, C. M. Vesa et al., “Pleotropic effects of polyphenols in cardiovascular system,” Biomedicine & Pharmacotherapy, vol. 130, p. 110714, 2020.	2020
11	F. I. Hassan, T. Didari, F. Khan, K. Niaz, M. Mojtahedzadeh, and M. Abdollahi, “A review on the protective effects of metformin in sepsis-induced organ failure,” Cell Journal (Yakhteh), vol. 21, no. 4, p. 363, 2020.	2020
12	M. Hodjat, F. Khan, and K. A. Saadat, “Epigenetic alterations in aging tooth and the reprogramming potential,” Ageing Research Reviews, vol. 63, p. 101140, 2020.	2020
13	F. Khan, S. Momtaz, and M. Abdollahi, “The relationship between mercury exposure and epigenetic alterations regarding human health, risk assessment and diagnostic strategies,” Journal of Trace Elements in Medicine and Biology, vol. 52, pp. 37–47, 2019.	2019
14	J. Fang, A. Sureda, A. S. Silva, F. Khan, S. Xu, and S. M. Nabavi, “Trends of tea in cardiovascular health and disease: A critical review,” Trends in Food Science & Technology, vol. 88, pp. 385–396, 2019.	2019
15	F. I. Hassan, T. Didari, F. Khan, M. Mojtahedzadeh, and M. Abdollahi, “The role of epigenetic alterations involved in sepsis: An overview,” Current Pharmaceutical Design, vol. 24, no. 24, pp. 2862–2869, 2018.	2018
16	S. Momtaz, S. Hassani, F. Khan, M. Ziaee, and M. Abdollahi, “Cinnamon, a promising prospect towards Alzheimer’s disease,” Pharmacological Research, vol. 130, pp. 241–258, 2018.	2018
17	F. I. Hassan, T. Didari, F. Khan, M. Mojtahedzadeh, and M. Abdollahi, “The role of epigenetic alterations involved in sepsis: An overview,” Current Pharmaceutical Design, vol. 24, no. 24, pp. 2862–2869, 2018.	2018
18	K. Niaz, F. Maqbool, F. Khan, F. I. Hassan, S. Momtaz, and M. Abdollahi, “Comparative occurrence of diabetes in canine, feline, and few wild animals and their association with pancreatic diseases and ketoacidosis with therapeutic approach,” Veterinary World, vol. 11, no. 4, p. 410, 2018.	2018
19	F. Khan, S. Momtaz, K. Niaz, F. I. Hassan, and M. Abdollahi, “Epigenetic mechanisms underlying the toxic effects associated with arsenic exposure and the development of diabetes,” Food and Chemical Toxicology, vol. 107, pp. 406–417, 2017.	2017
20	F. Khan, K. Niaz, F. Ismail Hassan, and M. Abdollahi, “An evidence-based review of the genotoxic and reproductive effects of sulfur mustard,” Archives of Toxicology, vol. 91, pp. 1143–1156, 2017.	2017
21	F. I. Hassan, K. Niaz, F. Khan, F. Maqbool, and M. Abdollahi, “The relation between rice consumption, arsenic contamination, and prevalence of diabetes in South Asia,” EXCLI Journal, vol. 16, p. 1132, 2017.	2017
22	M. Hodjat, S. Rahmani, F. Khan, K. Niaz, M. Navaei-Nigjeh, S. Mohammadi Nejad, and M. Abdollahi, “Environmental toxicants, incidence of degenerative diseases, and therapies from the epigenetic point of view,” Archives of Toxicology, vol. 91, pp. 2577–2597, 2017.	2017
23	B. Larijani, K. Niaz, A. Pourabbasi, F. Khan, J. Spoor, and M. Abdollahi, “Not only Iranian rise in science marred by fraud: Misconduct is a global problem,” EXCLI Journal, vol. 16, p. 1099, 2017.	2017
24	F. Maqbool, K. Niaz, F. I. Hassan, F. Khan, and M. Abdollahi, “Immunotoxicity of mercury: Pathological and toxicological effects,” Journal of Environmental Science and Health, Part C, vol. 35, no. 1, pp. 29–46, 2017.	2017
25	K. Niaz, F. I. Hassan, F. Maqbool, F. Khan, S. Momtaz, M. Baeeri, M. Navaei-Nigjeh, M. Rahimifard, and M. Abdollahi, “Effect of styrene exposure on plasma parameters, molecular mechanisms and gene expression in rat model islet cells,” Environmental Toxicology and Pharmacology, vol. 54, pp. 62–73, 2024.	2024
26	K. Niaz, F. Khan, F. Maqbool, S. Momtaz, F. I. Hassan, N. Nobakht-Haghighi, M. Rahimifard, and M. Abdollahi, “Endo-cannabinoids system and the toxicity of cannabinoids with a biotechnological approach,” EXCLI Journal, vol. 16, p. 688, 2017.	2017
27	F. I. Hassan, K. Niaz, F. Khan, F. Maqbool, and M. Abdollahi, “The relation between rice consumption, arsenic contamination, and prevalence of diabetes in South Asia,” EXCLI Journal, vol. 16, p. 1132, 2017.	2017
28	K. Niaz, F. Maqbool, F. Khan, H. Bahadar, F. I. Hassan, and M. Abdollahi, “Smokeless tobacco (paan and gutkha) consumption, prevalence, and contribution to oral cancer,” Epidemiology and Health, vol. 39, p. e2017009, 2017.	2017
29	F. Khan, K. Niaz, F. Maqbool, F. Ismail Hassan, M. Abdollahi, K. C. Nagulapalli Venkata, S. M. Nabavi, and A. Bishayee, “Molecular targets underlying the anticancer effects of quercetin: An update,” Nutrients, vol. 8, no. 9, p. 529, 2016.	2016

SR.	CONFERENCE PUBLICATIONS	YEAR
1	K. Niaz, F. Maqbool, F. Khan, F. I. Hassan, M. Baeeri, M. Navaei-Nigjeh, S. Hassani, and M. Abdollahi, “Assessment of molecular mechanism(s) of styrene toxicity in blood plasma and liver,” Toxicology Letters, vol. 280, no. s1, pp. S212–S212, 2017.	2017
2	K. Niaz, F. I. Hassan, F. Maqbool, F. Khan, S. Momtaz, M. Baeeri, M. Navaei-Nigjeh, M. Rahimifard, and M. Abdollahi, “Influence of styrene on plasma parameters and molecular expression of islets of Langerhans in rat model,” Toxicology Letters, vol. 280, pp. S169–S169, 2017.	2017

Our Team

Dr. Fazlullah Khan

PROFILE SUMMARY

Other Members